U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TORALIZUMAB
KX44A9HM0B
Investigational
General
Record Details
Names
11
Classification
3
Identifiers
7
Relationships
2
Active Moiety
1
Characteristic Attributes
2
TORALIZUMAB
KX44A9HM0B
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
HUMANIZED MOUSE
Sequence Type
UNKNOWN
Record UNII
KX44A9HM0B
Record Status
Validated (UNII)
Record Version
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TORALIZUMAB
Official Name
English
toralizumab [INN]
Common Name
English
ANTI-CD40L
Code
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER
Systematic Name
English
ANTI-CD 154 HUMAN-MOUSE MONOCLONAL ANTIBODY
Common Name
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of systemic lupus erythematosus.
FDA ORPHAN DRUG
119298
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of immune thrombocytopenic purpura
FDA ORPHAN DRUG
154302
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C152696
PRIMARY
INN
8232
PRIMARY
CAS
252662-47-8
PRIMARY
ChEMBL
CHEMBL2108747
PRIMARY
USAN
MM-32
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
YUF12AXR3B
CD40 LIGAND SOLUBLE
TARGET -> INHIBITOR
T169OM1T8L
CD40 LIGAND RECOMBINANT
TARGET -> INHIBITOR
Showing 1 to 2 of 2 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
KX44A9HM0B
TORALIZUMAB
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
MOL_WEIGHT:ESTIMATE
CHEMICAL
ESTIMATE 148426 DA (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
